VIEMED HEALTHCARE, INC.
Close on Oct 19, 2026
- Market cap
- $394.40M
- P/E (TTM)
- 26.6
- Dividend yield
- –
About Viemed Healthcare
Services-Misc Health & Allied Services, NEC, SIC 8090
Viemed Healthcare, Inc. supplies home medical equipment and post-acute clinical care services, primarily focusing on respiratory therapy, chronic disease management, and women's health. The company provides medical devices largely through rental arrangements, including invasive and non-invasive home ventilators, continuous positive airway pressure units, oxygen therapy equipment, and percussion vests. Additional offerings include home sleep apnea testing, lactation supplies such as breast pumps, and clinical recruitment services. Its client base consists of patients managing chronic illnesses like chronic obstructive pulmonary disease and neuromuscular disorders at home, along with healthcare institutions seeking supplemental clinical personnel.
The company operates across all 50 states within the United States. As of late 2025, its staff includes 401 licensed respiratory therapists, comprising nearly thirty percent of its total workforce. Viemed Healthcare maintains its principal executive offices in Lafayette, Louisiana, with registered corporate records offices situated in Vancouver, British Columbia.
Summary of the business section of Viemed Healthcare's latest annual report, written by StockData.
Company profile
Company
- Legal name
- VIEMED HEALTHCARE, INC.
- Founded
- 2016
- Headquarters
- Lafayette, LA
- Address
- 625 E. Kaliste Saloom Rd. 70508
- Phone
- (337) 504-3802
- Website
- viemed.com
- Employees
- 1,382, Dec 31, 2025
- Industry
- Services-Misc Health & Allied Services, NEC
- Incorporated in
- A1
- Fiscal year ends
- December 31
- Auditor
- Ernst & Young LLP, New Orleans, Louisiana
Stock & identifiers
- Ticker
- VMD
- Exchange
- Nasdaq
- Shares outstanding
- 38M, Jul 27, 2026
- Public float
- $238.79M, Jun 30, 2025
- Filer category
- Accelerated filer
- SEC CIK
- 1729149
- CUSIP
- 92663R105
- ISIN
- US92663R1059
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| William Frazier | Chief Medical Officer, Director | 83,214 |
| Casey Hoyt | Chief Executive Officer, Director | 2,349,320 |
| William Todd Zehnder | Chief Operating Officer, Director | 401,677 |
| Michael Moore | President | 1,774,902 |
| Jeremy Trahan | General Counsel | 49,431 |
| Jerome Cambre | Vice President of Sales | 106,443 |
| Trae Fitzgerald | Chief Financial Officer | 105,638 |
| Nitin Kaushal | Director | 161,361 |
| Sabrina Heltz | Director | 82,520 |
| Randy E. Dobbs | Director | 142,253 |
| Timothy Smokoff | Director | 94,304 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Casey Hoyt | $2.63M | $2.27M | $1.99M | $142 | $100 |
| FY2024 Casey Hoyt | $2.62M | $2.51M | $1.46M | $154 | $85 |
| FY2023 Casey Hoyt | $2.51M | $2.49M | $1.38M | $150 | $84 |
| FY2022 Casey Hoyt | $1.93M | $2.76M | $1.06M | $145 | $80 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“At December 31, 2025, Viemed had 1,382 permanent employees, in addition to temporary employees and independent contractors engaged through the Company's healthcare staffing and recruitment services to supplement the workforce needs of third-party healthcare facilities.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jun 1, 2023 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Jul 10, 2019 | Spin-off | Registration as a new public company (Form 10), e.g. spin-off |